OUR STORY
Enabling people with diabetes
to live a better life
OUR STORY
Enabling people with diabetes
to live a better life
Enabling people with diabetes to live a better life
Guidepost was established in 2012 to help improve the quality of life of people living with diabetes, a condition that affects more than 400 million people globally. Led by a team of medical doctors, scientists and AI specialists, we are committed to finding solutions to help as many people living with diabetes as possible.
There have been major advances in the treatment of diabetes, including new devices, technology and advice, but diabetes remains largely a self-care condition. To live a healthier life, and to reduce hospitalisations, diabetics need to pay close attention to their diet and lifestyle choices. This, more often than not, requires significant behaviour change, which is difficult to achieve without ongoing support.
We strive to lessen this burden, by offering sophisticated, personalized coaching, powered by AI. We have developed a platform that enables our more than 100 clinically trained professional coaches to proactively engage with people living with diabetes, providing unparalleled, personalized support.
Insurers and device makers have recognized the significant benefits of our offering and are providing our service to their clients. With Guidepost, they are able to help their clients to better manage their diabetes. This keeps them healthier and on treatment, resulting in better outcomes, which ultimately ensures that our partners’ businesses flourish too.
THE AI OPPORTUNITY
Putting our data to work
Every diabetes patient is unique and there are thousands of possible combinations of patient, barrier and necessary intervention to get the best results. To be able to scale to meet the massive demand for personalised coaching, we need expert clinical judgement at the touch of a button.
Over the last decade, there have been more than 1.2 million calls placed between coaches and clients. This has amassed a significant and unique data set. With the latest advances in machine learning, and specifically deep learning, we are finally at a point where we can support our coaches by helping automate complex judgement that managing diabetes requires. This presents an unparalleled opportunity to scale because our coaches now have the tools at their fingertips to work much faster with less training.
THE AI OPPORTUNITY
Putting our data to work
Every diabetes patient is unique and there are thousands of possible combinations of patient, barrier and necessary intervention to get the best results. To be able to scale to meet the massive demand for personalised coaching, we need expert clinical judgement at the touch of a button.
Over the last decade, there have been more than 1.2 million calls placed between coaches and clients. This has amassed a significant and unique data set. With the latest advances in machine learning, and specifically deep learning, we are finally at a point where we can support our coaches by helping automate complex judgement that managing diabetes requires. This presents an unparalleled opportunity to scale because our coaches now have the tools at their fingertips to work much faster with less training.
Our team
Graham Rowe
Ceo and co-founder
Professor David Segal
Chief medical officer and Co-founder
Jacob Flanders
Product Lead
Greg Van Berkel
Chief technology Officer
Renier van Rooyen
AI Lead
Tracy Hesslewood
Solutions & Quality Executive
Alexandra Menego
Operations Executive
Our team
Graham Rowe
Ceo and co-founder
Jacob Flanders
Product Lead
Renier van Rooyen
AI Lead
Alexandra Menego
Operations Executive
Professor David Segal
Chief medical officer and Co-founder
Greg Van Berkel
Chief technology Officer
Tracy Hesslewood
Solutions & Quality Executive
Our team
Graham Rowe
Ceo and co-founder
Professor David Segal
Chief medical officer and Co-founder
Jacob Flanders
Product Lead
Greg Van Berkel
Chief technology Officer
Renier van Rooyen
AI Lead
Tracy Hesslewood
Solutions & Quality Executive
Alexandra Menego
Operations Executive
Our board
Graham Rowe
Ceo and co-founder
Professor David Segal
Chief medical officer and Co-founder
Herschel Mayers
Non-Exec Chairman
Marc Herson
Observer
Dominique Collett
Non-Exec
John Seymour
Non-Exec
Richard Johnson
Non-Exec
Our board
Graham Rowe
Ceo and co-founder
Herschel Mayers
Non-Exec Chairman
Dominique Collett
Non-Exec
Richard Johnson
Non-Exec
Professor David Segal
Chief medical officer and Co-founder
Marc Herson
Observer
John Seymour
Non-Exec
Our board
Graham Rowe
Ceo and co-founder
Professor David Segal
Chief medical officer and Co-founder
Herschel Mayers
Non-Exec Chairman
Marc Herson
Observer
Dominique Collett
Non-Exec
John Seymour
Non-Exec
Richard Johnson
Non-Exec